AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Femara gets U.S. FDA nod as post-tamoxifen treatment for early breast cancer.
2004 DEC 2 - (NewsRx.com & NewsRx.net) -- Femara (letrozole tablets) is the first therapy approved by the U.S. Food and Drug Administration for the extended adjuvant treatment of postmenopausal women with early breast cancer who have received adjuvant (postsurgery) tamoxifen therapy for 5 years, Novartis announced.
"Femara truly provides hope to women who have survived early breast cancer by offering them an improved chance of remaining cancer-free," said Diane Young, MD, vice president, global head, clinical development, Novartis oncology. "This priority review approval marks the first time that the nearly 100,000 women in the United States who complete tamoxifen therapy each year will have a medical option to reduce their ongoing risk of breast cancer recurrence."
The approval for the extended adjuvant indication was based on results from the landmark, international, independent MA-17 study, ...
- Letrozole Offers Greater Protection From Recurrence of Early Breast Cancer Than...
- Press release article from: PR Newswire Europe May 13, 2005 700+ words
...in postmenopausal women with early breast cancer (19% less risk of recurrence...women with hormone sensitive early breast cancer," says PD Dr. Beat Thuerlimann...have a major impact on the way early breast cancer is treated in this population...
- Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
- Press release article from: PR Newswire December 10, 2002 700+ words
...in postmenopausal women with early breast cancer Novartis announced today that...in postmenopausal women with early breast cancer. The Novartis drugs being...community: 1) Does treating early breast cancer with an aromatase inhibitor...
- Goserelin a Viable Option for Early Breast Cancer.(Brief Article)
- Magazine article from: Family Practice News JANCIN, BRUCE April 1, 2001 700+ words
...adjunctive chemotherapy in many women with early breast cancer, Dr. Walter Jonat said at a breast cancer...receptor--positive, lymph node--positive breast cancer in the Zoladex Early Breast Cancer Research Association (ZEBRA) trial, reported...
- Trials Underway to Evaluate ARIMIDEX in Postmenopausal Women at High-Risk For...
- Press release article from: PR Newswire May 28, 2003 700+ words
...Europe in patients with very early breast cancer and in women at high risk for...hormone receptor- positive early breast cancer. ARIMIDEX is the only hormonal...that is approved in this early breast cancer setting. The effectiveness...
- The role of the breast care nurse during treatment for early breast cancer: the...
- Magazine article from: Contemporary Nurse Halkett, Georgia Arbon, Paul Scutter, Sheila Borg, Martin October 1, 2006 700+ words
...had completed treatment for early breast cancer. The women were asked to describe...role during the experience of early breast cancer. Oncology clinics should focus...Centre (NBCC) guidelines for early breast cancer (iSource National Breast Cancer...
- LETROZOLE CUTS RISK OF POST-SURGERY RECURRENCE OF EARLY BREAST CANCER.
- News wire article from: AsiaPulse News January 27, 2005 700+ words
...In postmenopausal women with early breast cancer, letrozole offers better post...today at the Primary Therapy of Early Breast Cancer 9th International Conference...women with endocrineresponsive early breast cancer. Methods and Results BIG 1...
- Letrozole Reduces the Risk of Post-Surgery Recurrence of Early Breast Cancer...
- Newspaper article from: PR Newswire Europe January 26, 2005 700+ words
...In postmenopausal women with early breast cancer, letrozole offers better post...today at the Primary Therapy of Early Breast Cancer 9th International Conference...women with endocrineresponsive early breast cancer. Methods and Results BIG 1...
- New 5-Year Data Reported Comparing ARIMIDEX(R) (anastrozole) to Tamoxifen in...
- Press release article from: PR Newswire December 8, 2004 700+ words
...Hormone Receptor-Positive Early Breast Cancer After 5 Years of Treatment...from the world's largest early breast cancer treatment trial (ATAC) report...positive postmenopausal women with early breast cancer. "It is crucial for women...